MARKET COMPOSITE
Market TodayThemes and Stocks SummaryThematic Stock SearchCrypto SummaryFAQAbout
MRK - Merck & Co Inc
$86.12
-0.52(-0.60%)8:04:05 PM 9/30/2022
Merck & Co., Inc., d.b.a. Merck Sharp & Dohme outside the United States and Canada, is an American multinational pharmaceutical company and one of the largest pharmaceutical companies in the world. Merck is incorporated in New Jersey. In 1887 a German-born, long-time Merck employee, Theodore Weicker, went to the United States to represent the Darmstadt firm. In 1891, with a capital of $200,000 received from E. Merck, Weicker started the American Merck & Co, with headquarters in lower Manhattan. That year George Merck, the twenty-three-year- old son of the then head of E. Merck joined Weicker in New York. The company was established as the United States subsidiary of the German company Merck, which was founded in 1668 by the Merck family. Merck & Co. was expropriated by the US government during World War I and subsequently established as an independent American company in 1917. While it operates as Merck & Co. in the United States and Canada, the original Merck based in Darmstadt holds the rights to the Merck name everywhere else. Merck & Co. is the world's seventh largest pharmaceutical company by market capitalization and revenue. Its headquarters is located in Kenilworth, New Jersey. The company ranked No. 78 in the 2018 Fortune 500 list of the largest United States corporations by total revenue.
Stock Chart

Short Volume Ratio = Short Volume / All Volume. Source of Short Volume data comes from 

Finra

Moving Average Convergence/Divergence oscillator (MACD) is one of the simplest and most effective momentum indicators available.

Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. RSI oscillates between zero and 100. According to Wilder, RSI is considered overbought when above 70 and oversold when below 30.

No summary
Related Topics
Peers

Stock news

    09/29/2022MRK
    U.S. Court of Appeals for the Federal Circuit Rules in Favor of Merck in Sitagliptin Dihydrogen Phosphate Patent Lawsuit

    RAHWAY, N.J., September 29, 2022--Merck (NYSE: MRK), known as MSD outside of the United States and Canada, announced today that the U.S. Court of Appeals for the Federal Circuit ruled in favor of the company in a patent challenge brought by Mylan Pharmaceuticals, Inc. (now Viatris) related to sitagliptin dihydrogen phosphate, an active ingredient in JANUVIA® (sitagliptin), JANUMET® (sitagliptin and metformin hydrochloride) and JANUMET® XR (sitagliptin and metformin hydrochloride extended-release

    09/29/2022MRK
    Merck wins ruling upholding diabetes-treatment patent at U.S. appeals court

    A Merck Sharp & Dohme Corp patent related to its diabetes drugs Januvia and Janumet is valid, a U.S. appeals court said Thursday, rejecting a challenge to the patent by generic drugmaker Mylan Pharmaceuticals Inc. Viatris Inc's Mylan failed to convince the U.S. Court of Appeals for the Federal Circuit that the patent was invalid based on an earlier patent and other publications.

    09/29/2022MRK
    Merck Inks Supply Deal With Sinopharm To Commercialize COVID-19 Pills In China

    Merck & Co Inc (NYSE: MRK) signed a cooperation framework agreement in China for its COVID-19 antiviral pills, which were co-developed by Ridgeback Therapeutics. The pharma giant has granted Sinopharm exclusive import and distribution rights to Lagevrio (molnupiravir). The companies will also negotiate the feasibility of a technical transfer under the framework so that the drug Molnupiravir could be produced and provided in the Chinese mainland market, Global Times reported. While Pfizer's pills

    09/29/2022MRK
    Merck to Hold Third-Quarter 2022 Sales and Earnings Conference Call October 27

    RAHWAY, N.J., September 29, 2022--Merck (NYSE: MRK), known as MSD outside the United States and Canada, will hold its third-quarter 2022 sales and earnings conference call with institutional investors and analysts at 8:00 a.m. ET on Thursday, October 27. During the call, company executives will provide an overview of Merck’s performance for the quarter and outlook.

    09/28/2022MRK
    11 Best Dividend Paying Stocks To Buy Now

    In this article, we discuss 11 best dividend-paying stocks to buy now. You can skip our detailed analysis of dividend stocks and their returns, and go directly to read 5 Best Dividend Paying Stocks To Buy Now. Dividend companies are gaining ground among investors this year as they navigate the rocky market. In times of financial […]

    09/28/2022MRK
    Merck agrees to allow Sinopharm to sell molnupiravir COVID drug in China

    Drugmaker Merck & Co said on Wednesday that it agreed to allow China's Sinopharm to distribute and import its COVID-19 antiviral molnupiravir in China if the drug is approved for use there. The drugmaker said in a statement that it reached a cooperation framework agreement with Sinopharm that grants the Chinese company distribution and exclusive import rights of the medicine in the China mainland market. Merck also said it will allow China National Biotec Group, an affiliate of Sinopharm, to m...

    09/28/2022MRK
    Merck's (MRK) Keytruda Gets Four New Approvals in Japan

    The Ministry of Health, Labour and Welfare approves Merck's (MRK) anti-PD-1 therapy, Keytruda, for four new cancer indications in Japan.

    09/28/2022MRK
    10 High Dividend Stocks Picked by Billionaire Gabelli

    In this article, we discuss 10 high dividend stocks picked by billionaire Gabelli. You can skip our detailed analysis of GAMCO Investors’ investment philosophy and its performance, and go directly to read 5 High Dividend Stocks Picked by Billionaire Gabelli. Mario Gabelli built his reputation as one of Wall Street’s most successful investors when he […]

    09/28/2022MRK
    Bear Market: 2 Safe Stocks to Buy Right Now

    These businesses might be slightly "boring," but that may just be a good thing in today's market.